DAB2 is a well-established tumor-suppressor and a cytoplasmic adaptor molecule, has been shown to link cell surface receptors to downstream signal transduction, especially the ERK [13–15], Wnt/β-catenin [16–18] and TGF-β signaling pathway [19, 20]. Here, CD177 is linked to neoplasm.